Literature DB >> 3989434

Frequency of moles in a defined population.

K R Cooke, G F Spears, D C Skegg.   

Abstract

The occurrence of moles was studied in a community survey of 872 adults, using criteria that allowed comparison with two earlier surveys. Men and women had similar numbers of moles-on average, 15 moles of diameter 2 mm or greater, and 39 moles of all sizes. The frequency of moles declined with age and varied according to body site. Comparison of the findings with those of previous surveys-in New York in about 1950 and in Sydney in about 1970-suggested that the frequency of moles has increased as malignant melanoma has become more common. Little is known about the epidemiology of moles, which may hold the key to the explanation of the rising incidence of melanoma in many countries.

Entities:  

Mesh:

Year:  1985        PMID: 3989434      PMCID: PMC1052400          DOI: 10.1136/jech.39.1.48

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  10 in total

1.  Natural regression of the melanocytic nevus.

Authors:  O C STEGMAIER
Journal:  J Invest Dermatol       Date:  1959-03       Impact factor: 8.551

2.  Regional distribution of moles and melanomas.

Authors:  G T PACK; N LENSON; D M GERBER
Journal:  AMA Arch Surg       Date:  1952-12

3.  Development and elimination of pigmented moles, and the anatomical distribution of primary malignant melanoma.

Authors:  E M Nicholls
Journal:  Cancer       Date:  1973-07       Impact factor: 6.860

4.  Histopathology of borderline and early malignant melanomas.

Authors:  R W Sagebiel
Journal:  Am J Surg Pathol       Date:  1979-12       Impact factor: 6.394

5.  Further surveys in Milton, 1978 and 1981: blood pressure, height, weight and 24-hour excretion of sodium and potassium.

Authors:  F O Simpson; J M Paulin; E L Phelan; B I Thaler; H J Waal-Manning; E R Nye; G P Herbison
Journal:  N Z Med J       Date:  1982-12-22

6.  Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'.

Authors:  W H Clark; R R Reimer; M Greene; A M Ainsworth; M J Mastrangelo
Journal:  Arch Dermatol       Date:  1978-05

7.  Multiple melanoma and atypical melanocytic naevi--evidence of an activated and expanded melanocytic system.

Authors:  R M MacKie
Journal:  Br J Dermatol       Date:  1982-12       Impact factor: 9.302

8.  Trends in malignant melanoma of skin in New Zealand.

Authors:  K R Cooke; D C Skegg; J Fraser
Journal:  Int J Cancer       Date:  1983-06-15       Impact factor: 7.396

9.  Melanoma in New South Wales: an epidemiologic surgery 1970--76.

Authors:  W H McCarthy; A L Black; G W Milton
Journal:  Cancer       Date:  1980-07-15       Impact factor: 6.860

10.  Melanoma in Otago and Southland.

Authors:  J P Scott; K D Jolly; M J MacKinnon; A M Clarke
Journal:  N Z Med J       Date:  1980-12-10
  10 in total
  5 in total

1.  Relation between phenotype and banal melanocytic naevi.

Authors:  J S English; A J Swerdlow; R M MacKie; C J O'Doherty; J A Hunter; J Clark; D J Hole
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-17

2.  Cross-sectional analysis of the dermoscopic patterns and structures of melanocytic naevi on the back and legs of adolescents.

Authors:  M Fonseca; M A Marchetti; E Chung; S W Dusza; M E Burnett; A A Marghoob; A C Geller; M Bishop; A Scope; A C Halpern
Journal:  Br J Dermatol       Date:  2015-10-27       Impact factor: 9.302

3.  Excess benign melanocytic naevi after chemotherapy for malignancy in childhood.

Authors:  B R Hughes; W J Cunliffe; C C Bailey
Journal:  BMJ       Date:  1989-07-08

4.  The association between naevi and melanoma in populations with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia.

Authors:  V Bataille; A Grulich; P Sasieni; A Swerdlow; J Newton Bishop; W McCarthy; P Hersey; J Cuzick
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

5.  Number and size of acquired melanocytic nevi and affecting risk factors in cases admitted to the dermatology clinic.

Authors:  Ayşegül Yalçınkaya İyidal; Ülker Gül; Arzu Kılıç
Journal:  Postepy Dermatol Alergol       Date:  2016-10-21       Impact factor: 1.837

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.